Treace Medical Concepts, Inc. TMCI Income Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $47.2M-10.2% | $62.52M-9.0% | $50.21M+11.4% | $47.39M+6.6% | $52.57M+2.9% | ||
| $9.79M-8.3% | $12.12M-8.4% | $10.51M+17.4% | $9.64M+9.7% | $10.68M+5.4% | ||
| $37.41M-10.7% | $50.4M-9.1% | $39.71M+9.9% | $37.75M+5.8% | $41.89M+2.2% | ||
| 79.3%-0.4pp | 80.6%-0.1pp | 79.1%-1.1pp | 79.7%-0.6pp | 79.7%-0.5pp | ||
| $4.62M-16.9% | $4.54M-12.8% | $4.68M-5.7% | $5.5M+6.6% | $5.56M+5.8% | ||
| $33.78M-6.5% | $37.25M+1.1% | $34.42M+5.0% | $33.08M-12.2% | $36.12M-10.4% | ||
| $16.18M+2.4% | $14.53M+6.7% | $16.28M+20.4% | $16.14M+13.5% | $15.79M+9.9% | ||
| $54.57M-5.0% | $56.32M+1.2% | $55.38M+8.0% | $54.73M-4.1% | $57.48M-4.1% | ||
| $54.57M-5.0% | $56.32M+1.2% | $55.38M+8.0% | $54.73M-4.1% | $57.48M-4.1% | ||
| -$17.17M-10.2% | -$5.92M-2,803% | -$15.68M-3.6% | -$16.97M+20.6% | -$15.58M+17.9% | ||
| -36.4%-6.7pp | -9.5%-9.2pp | -31.2%+2.3pp | -35.8%+12.3pp | -29.6%+7.5pp | ||
| $1.57M+19.8% | $1.35M+2.7% | $1.34M+1.9% | $1.32M+0.7% | $1.31M-0.5% | ||
| $501K-40.4% | $527K-41.4% | $634K-40.6% | $775K-43.7% | $841K-45.2% | ||
| -$794K-134% | -$3.47M-1,069% | -$612K-171% | -$424K-341% | -$340K-216% | ||
| -$17.96M-12.8% | -$9.39M-1,775% | -$16.29M-6.0% | -$17.4M+18.0% | -$15.92M+14.7% | ||
| -38.1%-7.8pp | -15%-14.3pp | -32.4%+1.6pp | -36.7%+11.0pp | -30.3%+6.3pp | ||
| -$0.28-12.0% | -$0.14-1,300% | -$0.26-4.0% | -$0.28+17.6% | -$0.25+16.7% | ||
| -$0.28-12.0% | -$0.14-1,300% | -$0.26-4.0% | -$0.28+17.6% | -$0.25+16.7% | ||
| 64.6M+3.1% | 63.3M+1.9% | 63.5M+2.1% | 63M+1.5% | 62.7M+1.4% | ||
| 64.6M+3.1% | 63.3M+1.9% | 63.5M+2.1% | 63M+1.5% | 62.7M+1.4% | ||
| -$18.06M-13.1% | -$9.41M-1,481% | -$16.26M-7.3% | -$17.41M+18.3% | -$15.96M+15.0% | ||
| $501K-40.4% | $527K-41.4% | $634K-40.6% | $775K-43.7% | $841K-45.2% | ||
| -$794K-134% | -$3.47M-1,069% | -$612K-171% | -$424K-341% | -$340K-216% | ||
| $275K+112% | $88K-25.4% | $92K+360% | $122K+8.9% | $130K+75.7% | ||
| -$17.17M-10.2% | -$5.92M-2,803% | -$15.68M-3.6% | -$16.97M+20.6% | -$15.58M+17.9% | ||
| -$16.27M-24.0% | -$3.11M-253% | -$12.9M+0.6% | -$14.4M+25.3% | -$13.12M+23.1% | ||
| -$16.27M-24.0% | -$3.11M-253% | -$12.9M+0.6% | -$14.4M+25.3% | -$13.12M+23.1% | ||
| -34.5%-9.5pp | -5%-7.9pp | -25.7%+3.1pp | -30.4%+13.0pp | -25%+8.4pp | ||
| -$17.17M-10.2% | -$5.92M-2,803% | -$15.68M-3.6% | -$16.97M+20.6% | -$15.58M+17.9% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Treace Medical Concepts, Inc.'s revenue?
- Treace Medical Concepts, Inc. (TMCI) generated $207.3M in revenue over the trailing twelve months, down 1.7% year over year.
- Is Treace Medical Concepts, Inc. profitable?
- Treace Medical Concepts, Inc. is not currently profitable: it reported a net loss of $61.0M over the trailing twelve months, a -29.4% net margin.
- What are Treace Medical Concepts, Inc.'s profit margins?
- Gross margin is 79.7% and operating margin is -26.9%, with a -29.4% net margin.
- What is Treace Medical Concepts, Inc.'s earnings per share?
- Treace Medical Concepts, Inc.'s diluted EPS over the trailing twelve months is $-0.96.
- Where does Treace Medical Concepts, Inc.'s income statement data come from?
- Every line is extracted from Treace Medical Concepts, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
